Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019936717> ?p ?o ?g. }
- W2019936717 endingPage "14" @default.
- W2019936717 startingPage "7" @default.
- W2019936717 abstract "Azacitidine is a cytidine analog used in the treatment of myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia. The pharmacological effect of azacitidine arises after incorporation into the DNA and RNA. To this end, the drug first has to be converted into its triphosphate forms. This paper describes the development of an assay for quantitative determination of azacitidine triphosphate (aza-CTP) in peripheral blood mononuclear cells (PBMCs). To quantify aza-CTP, separation from the endogenous nucleotides cytidine triphosphate (CTP) and uridine triphosphate (UTP) is required. This was a challenge as the structures of these nucleotides are highly similar and the monoisotopic molecular masses of aza-CTP, UTP and the naturally occurring [(13)C]- and [(15)N]-isotopes of CTP differ less than 0.02 Da. Efforts to select a specific MS(2)-fragment for aza-CTP using a triple quadrupole mass spectrometer remained without success. Therefore, we investigated the feasibility to separate these highly resembling nucleotides based on accurate mass spectrometry using a linear trap quadrupole (LTQ) coupled with an Orbitrap. The LTQ-Orbitrap was able to differentiate between aza-CTP and the endogenous nucleotides UTP and [(13)C]-CTP. There was no baseline resolution between aza-CTP and [(15)N]-CTP, but the [(15)N]-CTP interference was low. For quantification, extracted ion chromatograms were obtained for the accurate m/z window of the aza-CTP product ion. The assay was able to determine aza-CTP concentrations in PBMC lysate from 40.7 to 281 nM. Assuming that an average cell suspension extracted from 16 mL blood contains 10 to 42 million PBMCs per mL, this range corresponds with 2.58/10.9-17.8/74.9 pmol aza-CTP per million PBMCs. Intra-assay accuracies were between -1.1 and 9.5% deviation and coefficient of variation values were ≤13.2%. The assay was successfully applied to quantify aza-CTP in samples from two patients treated with azacitidine. Aza-CTP concentrations up to 19.0 pmol per million PBMCs were measured. This is the first time that aza-CTP concentrations were quantified in PBMCs from patients treated with azacitidine." @default.
- W2019936717 created "2016-06-24" @default.
- W2019936717 creator A5000418012 @default.
- W2019936717 creator A5006789264 @default.
- W2019936717 creator A5041259777 @default.
- W2019936717 creator A5051535029 @default.
- W2019936717 creator A5052836154 @default.
- W2019936717 creator A5062227574 @default.
- W2019936717 creator A5067607823 @default.
- W2019936717 date "2014-03-01" @default.
- W2019936717 modified "2023-10-02" @default.
- W2019936717 title "Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometry" @default.
- W2019936717 cites W1966550393 @default.
- W2019936717 cites W1978424858 @default.
- W2019936717 cites W1979806945 @default.
- W2019936717 cites W1998101586 @default.
- W2019936717 cites W2017394727 @default.
- W2019936717 cites W2024596788 @default.
- W2019936717 cites W2036076857 @default.
- W2019936717 cites W2044980847 @default.
- W2019936717 cites W2047169010 @default.
- W2019936717 cites W2051510417 @default.
- W2019936717 cites W2059549803 @default.
- W2019936717 cites W2064634236 @default.
- W2019936717 cites W2080270409 @default.
- W2019936717 cites W2086492419 @default.
- W2019936717 cites W2091084027 @default.
- W2019936717 cites W2113543636 @default.
- W2019936717 cites W2127289529 @default.
- W2019936717 doi "https://doi.org/10.1016/j.jpba.2013.11.010" @default.
- W2019936717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24317024" @default.
- W2019936717 hasPublicationYear "2014" @default.
- W2019936717 type Work @default.
- W2019936717 sameAs 2019936717 @default.
- W2019936717 citedByCount "15" @default.
- W2019936717 countsByYear W20199367172014 @default.
- W2019936717 countsByYear W20199367172015 @default.
- W2019936717 countsByYear W20199367172016 @default.
- W2019936717 countsByYear W20199367172017 @default.
- W2019936717 countsByYear W20199367172018 @default.
- W2019936717 countsByYear W20199367172019 @default.
- W2019936717 countsByYear W20199367172020 @default.
- W2019936717 countsByYear W20199367172021 @default.
- W2019936717 countsByYear W20199367172023 @default.
- W2019936717 crossrefType "journal-article" @default.
- W2019936717 hasAuthorship W2019936717A5000418012 @default.
- W2019936717 hasAuthorship W2019936717A5006789264 @default.
- W2019936717 hasAuthorship W2019936717A5041259777 @default.
- W2019936717 hasAuthorship W2019936717A5051535029 @default.
- W2019936717 hasAuthorship W2019936717A5052836154 @default.
- W2019936717 hasAuthorship W2019936717A5062227574 @default.
- W2019936717 hasAuthorship W2019936717A5067607823 @default.
- W2019936717 hasConcept C104317684 @default.
- W2019936717 hasConcept C150194340 @default.
- W2019936717 hasConcept C153911025 @default.
- W2019936717 hasConcept C162356407 @default.
- W2019936717 hasConcept C181199279 @default.
- W2019936717 hasConcept C185592680 @default.
- W2019936717 hasConcept C190727270 @default.
- W2019936717 hasConcept C2776239401 @default.
- W2019936717 hasConcept C2778564976 @default.
- W2019936717 hasConcept C2780841973 @default.
- W2019936717 hasConcept C2781184954 @default.
- W2019936717 hasConcept C2781259782 @default.
- W2019936717 hasConcept C43617362 @default.
- W2019936717 hasConcept C512185932 @default.
- W2019936717 hasConcept C55493867 @default.
- W2019936717 hasConcept C67705224 @default.
- W2019936717 hasConcept C83387232 @default.
- W2019936717 hasConcept C86803240 @default.
- W2019936717 hasConceptScore W2019936717C104317684 @default.
- W2019936717 hasConceptScore W2019936717C150194340 @default.
- W2019936717 hasConceptScore W2019936717C153911025 @default.
- W2019936717 hasConceptScore W2019936717C162356407 @default.
- W2019936717 hasConceptScore W2019936717C181199279 @default.
- W2019936717 hasConceptScore W2019936717C185592680 @default.
- W2019936717 hasConceptScore W2019936717C190727270 @default.
- W2019936717 hasConceptScore W2019936717C2776239401 @default.
- W2019936717 hasConceptScore W2019936717C2778564976 @default.
- W2019936717 hasConceptScore W2019936717C2780841973 @default.
- W2019936717 hasConceptScore W2019936717C2781184954 @default.
- W2019936717 hasConceptScore W2019936717C2781259782 @default.
- W2019936717 hasConceptScore W2019936717C43617362 @default.
- W2019936717 hasConceptScore W2019936717C512185932 @default.
- W2019936717 hasConceptScore W2019936717C55493867 @default.
- W2019936717 hasConceptScore W2019936717C67705224 @default.
- W2019936717 hasConceptScore W2019936717C83387232 @default.
- W2019936717 hasConceptScore W2019936717C86803240 @default.
- W2019936717 hasLocation W20199367171 @default.
- W2019936717 hasLocation W20199367172 @default.
- W2019936717 hasOpenAccess W2019936717 @default.
- W2019936717 hasPrimaryLocation W20199367171 @default.
- W2019936717 hasRelatedWork W1491244086 @default.
- W2019936717 hasRelatedWork W1788170015 @default.
- W2019936717 hasRelatedWork W1963809934 @default.
- W2019936717 hasRelatedWork W1982840609 @default.
- W2019936717 hasRelatedWork W2019936717 @default.
- W2019936717 hasRelatedWork W2053676465 @default.